7730.T

Mani, Inc. [7730.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

7730.T Stock Summary

Earnings have grown 19.95% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

7730.T has less than 1 year of cash runway

An RSI reading of 30 or below indicates an oversold or undervalued condition.

Top 10 Correlated ETFs

7730.T

Top 10 Correlated Stocks

7730.T

In the News

7730.T Financial details

Company Rating

Buy

Market Cap

176.51B

Income

6.58B

Revenue

26.37B

Book val./share

Cash/share

Dividend

Dividend %

1.48%

Employees

3.69K

Optionable

Shortable

Yes

Earnings

11 Jul 2024

P/E

36.85

Forward P/E

PEG

15.15

P/S

8.58

P/B

4.4

P/C

P/FCF

Quick Ratio

6.58

Current Ratio

8.3

Debt / Equity

LT Debt / Equity

EPS (TTM)

66.82

EPS next Y

EPS next Q

EPS this Y

12.47%

EPS next Y

EPS next 5Y

EPS last 5Y

-0.5%

Revenue last 5Y

5.97%

Revenue Q/Q

-4.5%

EPS Q/Q

2.88%

SMA20

-10.85%

SMA50

-12.92%

SMA100

-14.81%

Inst Own

Inst Trans

ROA

11%

ROE

13%

ROC

0.14%

Gross Margin

63%

Oper. Margin

30%

Profit Margin

24%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

1602.5-2410.0

52W High

-26.56%

52W Low

+10.49%

RSI

Rel Volume

2.19

Avg Volume

255.9K

Volume

560.3K

Perf Week

-2.37%

Perf Month

-16.75%

Perf Quarter

-13.68%

Perf Half Y

-12.05%

Beta

0.185

Volatility

14.74%, 100.43%

Prev Close

-1.17%

Price

1770

Change

-1.12%

7730.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-08-31

Metric	2019-08-31	2020-08-31	2021-08-31	2022-08-31	2023-08-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	186.2	154.43	174.65	207.42	248.68
Net income per share	61.99	33.82	43.6	53.75	60.45
Operating cash flow per share	53.9	19.73	64.86	66.64	81.51
Free cash flow per share	40.42	2.53	25.63	46.89	43.73
Cash per share	171.81	176.55	191.97	237.48	274.76
Book value per share	358.92	371.51	398.28	461.39	506
Tangible book value per share	349.56	362.16	389.19	450.89	493.37
Share holders equity per share	358.92	371.51	398.28	461.39	506
Interest debt per share	0	0.66	1.31	1.21	0.61
Market cap	244.39B	264.57B	214.27B	172.84B	186.85B
Enterprise value	227.48B	247.46B	196.11B	150.22B	161.48B
P/E ratio	40.05	79.47	49.94	32.67	31.39
Price to sales ratio	13.33	17.41	12.47	8.47	7.63
POCF ratio	46.06	136.27	33.56	26.35	23.28
PFCF ratio	61.43	1.06K	84.93	37.45	43.39
P/B Ratio	6.92	7.24	5.47	3.81	3.75
PTB ratio	6.92	7.24	5.47	3.81	3.75
EV to sales	12.41	16.28	11.41	7.36	6.59
Enterprise value over EBITDA	32.4	42.68	27.31	16.24	16.36
EV to operating cash flow	42.88	127.46	30.72	22.9	20.12
EV to free cash flow	57.18	993.92	77.73	32.55	37.5
Earnings yield	0.02	0.01	0.02	0.03	0.03
Free cash flow yield	0.02	0	0.01	0.03	0.02
Debt to equity	0	0	0	0	0
Debt to assets	0	0	0	0	0
Net debt to EBITDA	-2.41	-2.95	-2.53	-2.44	-2.57
Current ratio	7.01	13.58	10.8	8.59	8.3
Interest coverage	39.9K	2.06K	5.35K	3.08K	3.62K
Income quality	0.63	0.4	1.06	0.88	1
Dividend Yield	0.01	0.01	0.01	0.01	0.02
Payout ratio	0.29	0.62	0.5	0.45	0.53
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.09	0.1	0.09	0.08	0.09
Intangibles to total assets	0.02	0.02	0.02	0.02	0.02
Capex to operating cash flow	-0.25	-0.87	-0.6	-0.3	-0.46
Capex to revenue	-0.07	-0.11	-0.22	-0.1	-0.15
Capex to depreciation	-0.97	-1.2	-2.51	-1.11	-1.94
Stock based compensation to revenue	0	0	0	0	0
Graham number	707.56	531.72	625.04	746.96	829.62
ROIC	0.12	0.08	0.1	0.1	0.11
Return on tangible assets	0.16	0.09	0.1	0.11	0.11
Graham Net	173.65	194.66	203.82	239.04	272.83
Working capital	21.8B	24.26B	25.07B	28.72B	30.78B
Tangible asset value	34.41B	35.65B	38.31B	44.38B	48.58B
Net current asset value	20.95B	23.46B	24.14B	27.8B	29.84B
Invested capital	0	0	0	0	0
Average receivables	2.25B	1.94B	1.74B	2.03B	2.24B
Average payables	160.86M	166.27M	152.84M	133.5M	135M
Average inventory	5.71B	6.26B	6.55B	6.47B	6.45B
Days sales outstanding	45.82	37.88	40.36	38.47	34.8
Days payables outstanding	9.96	10.26	9.21	5.17	6.4
Days of inventory on hand	320.51	455.58	381.52	301.6	258.43
Receivables turnover	7.97	9.64	9.04	9.49	10.49
Payables turnover	36.64	35.57	39.65	70.64	57.02
Inventory turnover	1.14	0.8	0.96	1.21	1.41
ROE	0.17	0.09	0.11	0.12	0.12
Capex per share	-13.48	-17.2	-39.23	-19.75	-37.78

Quarterly Fundamentals Overview

Last date of statement is 2024-02-29 for Q2

Metric	2023-02-28	2023-05-31	2023-08-31	2023-11-30	2024-02-29
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	60.14	65.96	60.58	72.23	0
Net income per share	12.84	16.67	17.75	15.97	0
Operating cash flow per share	9.39	9.44	10.19	11.31	0
Free cash flow per share	9.39	9.44	10.19	11.31	0
Cash per share	257.49	240.1	274.69	228.35	0
Book value per share	469.08	477.11	505.86	502.49	0
Tangible book value per share	458.37	465.98	493.24	489.81	0
Share holders equity per share	469.08	477.11	505.86	502.49	0
Interest debt per share	0.82	0.68	0.59	0.43	0
Market cap	182.22B	161.32B	186.9B	216B	0
Enterprise value	158.94B	137.74B	161.53B	193.55B	-23.47B
P/E ratio	36.04	24.56	26.73	34.33	0
Price to sales ratio	30.78	24.83	31.32	30.36	0
POCF ratio	197.2	173.47	186.15	193.9	0
PFCF ratio	197.2	173.47	186.15	193.9	0
P/B Ratio	3.95	3.43	3.75	4.36	0
PTB ratio	3.95	3.43	3.75	4.36	0
EV to sales	26.85	21.2	27.07	27.21	-3.45
Enterprise value over EBITDA	88.94	60.76	74.2	82.68	-9.27
EV to operating cash flow	172.02	148.11	160.89	173.74	0
EV to free cash flow	172.02	148.11	160.89	173.74	0
Earnings yield	0.01	0.01	0.01	0.01	0
Free cash flow yield	0.01	0.01	0.01	0.01	0
Debt to equity	0	0	0	0	0
Debt to assets	0	0	0	0	0
Net debt to EBITDA	-13.02	-10.4	-11.65	-9.59	-9.27
Current ratio	8.88	8.96	8.3	7.4	9.12
Interest coverage	1.71K	1.97K	0	0	0
Income quality	0.73	0.57	0.57	0.71	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.08	0.09	0.1	0.08	0
Intangibles to total assets	0.02	0.02	0.02	0.02	0.02
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	368.13	423.05	449.44	424.92	0
ROIC	0.03	0.03	0.03	0.03	0.03
Return on tangible assets	0.03	0.03	0.03	0.03	0.03
Graham Net	259.11	242.25	272.76	225.51	0
Working capital	28.56B	28.9B	30.78B	27.62B	29.49B
Tangible asset value	45.12B	45.89B	48.58B	48.24B	50.33B
Net current asset value	27.62B	27.94B	29.84B	26.69B	28.54B
Invested capital	0	0	0	0	0
Average receivables	2.38B	2.4B	2.38B	2.36B	2.42B
Average payables	136.5M	163.5M	165.5M	166.5M	174.5M
Average inventory	6.03B	5.93B	6.19B	6.4B	6.46B
Days sales outstanding	35.91	33.71	35.22	30.11	32.6
Days payables outstanding	5.84	6.59	7.64	5.87	6.19
Days of inventory on hand	222.78	227.99	308.44	215.37	231.01
Receivables turnover	2.51	2.67	2.56	2.99	2.76
Payables turnover	15.41	13.66	11.78	15.33	14.55
Inventory turnover	0.4	0.39	0.29	0.42	0.39
ROE	0.03	0.03	0.04	0.03	0.03
Capex per share	0	0	0	0	0

7730.T Dividend History

7730.T Frequently Asked Questions

What is Mani, Inc. stock symbol ?

Mani, Inc. is a JP stock and trading under the symbol 7730.T

What is Mani, Inc. stock quote today ?

Mani, Inc. stock price is $1770 today.

Is Mani, Inc. stock public?

Yes, Mani, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 255.9K
Market Capitalization 176.51B
Employee 3.69K
CEO Mr. Masahiko Saito
Headquarters Utsunomiya,JP
IPO Date 2010-02-22
Website https://www.mani.co.jp

Mani, Inc. engages in the research, development, manufacture, and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, knives, stainless wire needles, and saws used in surgical operations for incision, cutting, and suture; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for eye surgeries, including cataract operations. It also provides surgical eyeless and eyed needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. In addition, the company imports and sells medical devices. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.